A carregar...
Novel Paclitaxel Nanoformulation Impairs De Novo Lipid Synthesis in Pancreatic Cancer Cells and Enhances Gemcitabine Efficacy
[Image: see text] Pancreatic cancer (PanCa) is a highly lethal disease with a poor 5 year survival rate, less than 7%. It has a dismal prognosis, and more than 50% of cases are detected at an advanced and metastatic stage. Gemcitabine (GEM) is a gold standard chemotherapy used for PanCa treatment. H...
Na minha lista:
| Publicado no: | ACS Omega |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Chemical Society
2020
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7178800/ https://ncbi.nlm.nih.gov/pubmed/32337462 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsomega.0c00793 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|